DC
WST icon

Davenport & Co’s West Pharmaceutical WST Stock Holding History

Davenport & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
10,722
+1,642
+18% +$502K 0.02% 425
2026
Q1 		$2.28M Sell
9,080
-441
-5% -$110K 0.01% 498
2025
Q4 		$2.62M Buy
9,521
+8,078
+560% +$2.21M 0.01% 471
2025
Q3 		$379K Sell
1,443
-905
-39% -$220K ﹤0.01% 989
2025
Q2 		$514K Buy
2,348
+118
+5% +$25.2K ﹤0.01% 866
2025
Q1 		$499K Buy
2,230
+1,136
+104% +$313K ﹤0.01% 840
2024
Q4 		$358K Buy
1,094
+309
+39% +$97.2K ﹤0.01% 945
2024
Q3 		$236K Buy
785
+54
+7% +$16.5K ﹤0.01% 1058
2024
Q2 		$241K Sell
731
-88
-11% -$31.1K ﹤0.01% 1027
2024
Q1 		$324K Buy
+819
New +$303K ﹤0.01% 923
2021
Q4 		– Sell
-574
Closed -$244K – 1123
2021
Q3 		$244K Buy
+574
New +$242K ﹤0.01% 924

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Davenport & Co's WST Position: Q2 2026 in Review

Davenport & Co increased its West Pharmaceutical (WST) stake by 18% in Q2 2026, buying an estimated $502K and bringing the position to 10,722 shares worth $3.85M. The position accounts for 0.02% of the portfolio, ranked #425.

Davenport & Co first reported a position in WST in Q3 2021 and has held it in 11 quarters since. 97 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Davenport & Co held 10,722 shares of West Pharmaceutical worth $3.85M as of Q2 2026.
  • Davenport & Co bought 1,642 West Pharmaceutical shares in Q2 2026, an estimated $502K.
  • West Pharmaceutical made up 0.02% of Davenport & Co's portfolio in Q2 2026, its #425 holding.
  • Davenport & Co first reported a position in West Pharmaceutical in Q3 2021 and has held it in 11 quarters since.
  • 97 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.